Cancer Letters
Volume 230, Issue 2 , Pages 271-283, 18 December 2005

5-Aza-2′-deoxycytidine induces retinoic acid receptor-β2 demethylation and growth inhibition in esophageal squamous carcinoma cells

  • Zhongmin Liu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Liyong Zhang

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • MOE Key Laboratory of Bioinformatics, Institute of Bioinformatics, Department of Automation, Tsinghua University, Beijing 100084, Peoples Republic of China
  • ,
  • Fang Ding

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Jie Li

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Mingzhou Guo

      Affiliations

    • Division of Tumor Biology, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
  • ,
  • Wendong Li

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Yunhai Wang

      Affiliations

    • Department of Thoracic Surgery, the First Affiliate Hospital of Anhui Medical University, Hefei 230022, Peoples Republic of China
  • ,
  • Zaicheng Yu

      Affiliations

    • Department of Thoracic Surgery, the First Affiliate Hospital of Anhui Medical University, Hefei 230022, Peoples Republic of China
  • ,
  • Qimin Zhan

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Min Wu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
  • ,
  • Zhihua Liu

      Affiliations

    • National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, Peoples Republic of China
    • Corresponding Author InformationCorresponding author. Tel./fax: +86 10 67723789.

Received 27 September 2004; received in revised form 7 January 2005; accepted 10 January 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(05)00062-5

doi:10.1016/j.canlet.2005.01.012

Cancer Letters
Volume 230, Issue 2 , Pages 271-283, 18 December 2005